001     305608
005     20251109023628.0
024 7 _ |a 10.1038/s41588-025-02389-7
|2 doi
024 7 _ |a pmid:41168397
|2 pmid
024 7 _ |a 1061-4036
|2 ISSN
024 7 _ |a 1546-1718
|2 ISSN
024 7 _ |a altmetric:183043660
|2 altmetric
037 _ _ |a DKFZ-2025-02258
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Rao, Shalini V
|b 0
245 _ _ |a Transcription factor switching drives subtype-specific pancreatic cancer.
260 _ _ |a London
|c 2025
|b Macmillan Publishers Limited, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1762172862_899166
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a epub
520 _ _ |a Emerging evidence suggests that lineage-specifying transcription factors control the progression of pancreatic ductal adenocarcinoma (PDAC). We have discovered a transcription factor switching mechanism involving the poorly characterized orphan nuclear receptor HNF4G and the putative pioneer factor FOXA1, which drives PDAC progression. Using our unbiased protein interactome discovery approach, we identified HNF4A and HNF4G as reproducible, FOXA1-associated proteins, in both preclinical models and Whipple surgical samples. In the primary tumor context, we consistently find that the dominant transcription factor is HNF4G, where it functions as the driver. A molecular switch occurs in advanced disease, whereby HNF4G expression or activity decreases, unmasking FOXA1's transcriptional potential. Derepressed FOXA1 drives late-stage disease by orchestrating metastasis-specific enhancer-promoter loops to regulate the expression of metastatic genes. Overall survival is influenced by HNF4G and FOXA1 activity in primary tumor growth and in metastasis, respectively. We suggest that the existence of stage-dependent transcription factor activity, triggered by molecular compartmentalization, mediates the progression of PDAC.
536 _ _ |a 899 - ohne Topic (POF4-899)
|0 G:(DE-HGF)POF4-899
|c POF4-899
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Young, Lisa
|b 1
700 1 _ |a Cheeseman, Danya
|b 2
700 1 _ |a Flynn, Sean
|b 3
700 1 _ |a Krebs, Niklas
|b 4
700 1 _ |a Couturier, Dominique-Laurent
|0 0000-0001-5774-5036
|b 5
700 1 _ |a Mack, Stephanie
|b 6
700 1 _ |a Brais, Rebecca
|b 7
700 1 _ |a Temple, Jill
|b 8
700 1 _ |a Smith, Amy
|b 9
700 1 _ |a Papachristou, Evangelia
|0 0000-0002-5835-2055
|b 10
700 1 _ |a Pelicano, Catarina
|0 0000-0002-7039-2922
|b 11
700 1 _ |a Chilamakuri, Chandra Sekhar Reddy
|b 12
700 1 _ |a Herka, Krzysztof
|b 13
700 1 _ |a Baba, Hideo
|b 14
700 1 _ |a Farah, Luay
|0 P:(DE-He78)e944dca7aa58866fd367bbf49f16de94
|b 15
|u dkfz
700 1 _ |a Cheung, Phyllis F
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Siveke, Jens
|0 P:(DE-He78)026e0a55b968f360a3c349689ce8a99c
|b 17
|u dkfz
700 1 _ |a Guerrier, Stéphane
|b 18
700 1 _ |a Insolia, Luca
|0 0000-0003-4169-5446
|b 19
700 1 _ |a Gill, Michael
|b 20
700 1 _ |a Archer Goode, Emily
|b 21
700 1 _ |a Kupczak, Steven
|b 22
700 1 _ |a Cheng, Yi
|b 23
700 1 _ |a Borsari, Giacomo
|0 0000-0002-0584-5737
|b 24
700 1 _ |a Jodrell, Duncan
|0 0000-0001-9360-1670
|b 25
700 1 _ |a D'Santos, Clive
|b 26
700 1 _ |a Russell, Alasdair
|b 27
700 1 _ |a Grünwald, Barbara T
|b 28
700 1 _ |a Serrao, Eva
|b 29
700 1 _ |a Chernukhin, Igor
|b 30
700 1 _ |a Carroll, Jason S
|0 0000-0003-3643-0080
|b 31
773 _ _ |a 10.1038/s41588-025-02389-7
|0 PERI:(DE-600)1494946-5
|p nn
|t Nature genetics
|v nn
|y 2025
|x 1061-4036
909 C O |o oai:inrepo02.dkfz.de:305608
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)e944dca7aa58866fd367bbf49f16de94
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)026e0a55b968f360a3c349689ce8a99c
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF4-890
|0 G:(DE-HGF)POF4-899
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-800
|4 G:(DE-HGF)POF
|v ohne Topic
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2025-01-01
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-01
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-01
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT GENET : 2022
|d 2025-01-01
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-01
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-01
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b NAT GENET : 2022
|d 2025-01-01
920 1 _ |0 I:(DE-He78)ED01-20160331
|k ED01
|l DKTK Koordinierungsstelle Essen/Düsseldorf
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)ED01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21